What LAI dosing option is available in week 2?

What LAI dosing option is available in week 2?

• A. 50 mg Q2 weeks
• B. 25 mg LAI Q2 weeks
• C. 25 mg daily
• D. 12.5 mg Q2 weeks

Answer: (B)

Long-acting injectables are given on a fixed interval to maintain steady antipsychotic levels and support adherence. For the risperidone long-acting injectable, the standard initiation schedule includes a second injection two weeks after the first. The dose used at that week-2 visit is 25 mg, administered every two weeks, with oral risperidone typically continued briefly to bridge the transition. This pairing ensures therapeutic coverage while the injectable reaches steady-state. Other options don’t reflect the common two-weekly LAI plan: daily 25 mg is oral rather than injectable, and the 12.5 mg or 50 mg options don’t align with the usual week-2 dosing pattern for this formulation.

Long-acting injectables are given on a fixed interval to maintain steady antipsychotic levels and support adherence. For the risperidone long-acting injectable, the standard initiation schedule includes a second injection two weeks after the first. The dose used at that week-2 visit is 25 mg, administered every two weeks, with oral risperidone typically continued briefly to bridge the transition. This pairing ensures therapeutic coverage while the injectable reaches steady-state. Other options don’t reflect the common two-weekly LAI plan: daily 25 mg is oral rather than injectable, and the 12.5 mg or 50 mg options don’t align with the usual week-2 dosing pattern for this formulation.